Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.50−0.02 (-1.32%)
Close on Nov 18, 2026Market cap $71.09MP/E –Yield –
Zhengye Biotechnology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was CN¥116.36M, down 37.6% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥116.36M | -37.6% |
| FY2024 | Dec 31, 2024 | CN¥186.36M | -12.0% |
| FY2023 | Dec 31, 2023 | CN¥211.65M | -18.7% |
| FY2022 | Dec 31, 2022 | CN¥260.27M | – |
See a number that looks wrong?